Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Elternimplementierte soziale Kommunikationsbehandlung bei Vorschulkindern mit Autismus-Spektrum-Störung

30. Oktober 2026 aktualisiert von: Patrick C. M. Wong, Chinese University of Hong Kong

Ein Predict-to-Prescribe-Ansatz zur Behandlung der sozialen Kommunikation bei chinesischen Vorschulkindern mit Autismus-Spektrum-Störung

An accumulation of research evidence has pointed to parent-implemented communication treatment as effective in reducing the severity of social communication deficits in preschool children with ASD. Despite even high-quality evidence, real-world translation to clinical practice remains challenging, especially for children from lower-income families, for two reasons. First, the treatment outcome is highly variable despite study-level efficacy data, most likely due to unique child and parent factors that make treatment response uneven across individual children. Second, the cost of intervention with the largest effect sizes remains high due to its one-on-one format.

With the overarching goal to reduce cost and to increase treatment effectiveness at the individual-child level, this project will conduct a randomized controlled trial (RCT) to compare the effectiveness of two options for intervention to address two specific objectives. The investigators will first ascertain whether parent-implemented communication treatment taught by a speech therapist in an Individual (one-on-one) format is more effective than treatment taught in a Group format (up to 8 families learning together) at the study level. The Individual format is at least 4 times more expensive than the Group format; its relative treatment effect must be empirically ascertained to justify its cost. The investigators will then evaluate what combinations of parent and child behavioral and neural factors determine which format of intervention is likely to be more effective at the individual-child level. It is likely that not all families require the more costly Individual format of intervention. Machine-learning analytics with cross-validation will be used in constructing predictive models of treatment response, which will increase the likelihood of these models being generalizable to new patients.

This study will be among the first examples of fulfilling the promise of Precision Medicine in providing guidance to patients and families with developmental disorders not about whether to receive intervention but which option for intervention to receive in the context of multiple options. This predict-to-prescribe approach of ASD intervention will likely lead to a paradigm shift in clinical practice and ultimately result in lowering the overall cost and increasing the effectiveness of intervention for children with ASD as individuals.

Studienübersicht

Detaillierte Beschreibung

BACKGROUND:

For parents of children with Autism Spectrum Disorder (ASD), the primary concern is to minimize the impact of the disorder, likely through evidence-based intervention. The secondary concern is whether any intervention prescribed is affordable and the logistics of completion feasible. This project will obtain evidence for ASD intervention options that have different costs and intervention delivery formats (individual vs. group) to evaluate whether a more costly option is more effective at the study level. The investigators will then develop a predict-to-prescribe approach that informs parents which intervention option would likely be most cost-effective in light of each family's unique characteristics (i.e., effectiveness at the individual-child level). [We use the term "parents" to mean caregivers throughout this protocol.]

ASD affects 14 per 10,000 (0.14%) children in Hong Kong and 39.23 per 10,000 in Mainland China. Social communication is a deficit domain of ASD, and about 29% of preschoolers with ASD have severe verbal deficits. Intervention through pharmaceutical means remains elusive, leaving behavioral interventions the most realistic and immediate avenue of treatment. This project will focus on enhancing the cost-effectiveness of behavioral intervention that targets language and communication. The investigators will do so in the context of precision medicine, in which the investigators aim to identify the most cost-effective intervention for the individual child with ASD.

AIM OF STUDY:

Objective 1: The investigators will first ascertain whether parent-implemented communication treatment taught by a speech therapist in an Individual (one-on-one) format is more effective than treatment taught in a Group format (up to 8 families learning together) at the study level.

Objective 2: The investigators will examine pre-treatment child and parent variables simultaneously and construct predictive models of response to the two treatment options (group, less costly vs. individual, more costly) at the individual-child level. Both neural and non-neural variables will be examined to increase the precision of prediction.

HYPOTHESIS:

By the investigators' estimate, even after the number of contact hours is controlled, the group format is at least 4 times cheaper than the one-on-one format. Individual sessions allow for individualization, clearer explanation and modeling of the strategies, as well as some clinician-to-child stimulations that cannot be achieved by lectures. Though it may seem obvious that this individual format must produce better results, it is possible that the group format may be more effective due to better social support offered by peers.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

144

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

      • Shatin, Hongkong
        • The Chinese University of Hong Kong
      • Tuenmen, Hongkong
        • Castle Peak Hospital

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

2 Jahre bis 5 Jahre (Kind)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Have a confirmed diagnosis of autism spectrum disorder or was evaluated to have elevated likelihood ("at-risk" or "suspected") by a Clinical Psychologist, Psychiatrist or Pediatrician who recommended continuous surveillance.
  • ADOS-2 score in the spectrum range (for Modules 1 & 2) or mild-to-moderate concern range (for Toddler Module)

Exclusion Criteria:

  • Mullen Scale of Early Learning non-verbal age at or less than 12 months
  • Parent who has severe psychological or neurological conditions prohibiting them from conducting the treatment program at home (restricted to only the parent in the program)
  • Children with any other severe developmental problems beyond autism spectrum disorder

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Group-based Parent-implemented Social Communication Training

A group-based parent-implemented social communication treatment program for up to 8 parents of children with autism spectrum disorder

A group-based social communication training for parents of preschoolers with autism spectrum disorder will be taught by a speech therapist online (approximately 25 hours distributed over 6 months), with up to 8 parents in a group.

Aktiver Komparator: Individual-based Parent-implemented Social Communication Training

An individual-based parent-implemented social communication treatment program for a parent of a child with autism spectrum disorder

An individual-based social communication training for parents of preschoolers with autism spectrum disorder will be taught by a speech therapist online in a one-on-one format (approximately 25 hours distributed over 6 months).

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change from Baseline Social Affect at 12 months
Zeitfenster: Baseline and at 12 months after the beginning of treatment

Comparing the pre- and post-treatment social affect measured by the Social Affect subscore of Autism Diagnostic Observation Schedule™, Second Edition (ADOS-2) between groups.

The Social Affect subscore of ADOS-2 ranges from 0 to 20; the higher ADOS-2 scores mean a worse outcome.

Baseline and at 12 months after the beginning of treatment
Change from Baseline Receptive Language at 12 months
Zeitfenster: Baseline and at 12 months after the beginning of treatment

Comparing the pre- and post-treatment receptive language measured by the Receptive Language domain of Mullen Scales of Early Learning (MSEL) between groups.

The MSEL score T-score ranges from 20 to 80; the higher MSEL scores mean a better outcome.

Baseline and at 12 months after the beginning of treatment
Change from Baseline Expressive Language at 12 months
Zeitfenster: Baseline and at 12 months after the beginning of treatment

Comparing the pre- and post-treatment expressive language measured by the Expressive Language domain of Mullen Scales of Early Learning (MSEL) between groups.

The MSEL score T-score ranges from 20 to 80; the higher MSEL scores mean a better outcome.

Baseline and at 12 months after the beginning of treatment

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change from Baseline Number of Parent-child Turn-taking at 6 months and 12 months
Zeitfenster: Baseline, at 6 months and at 12 months after the beginning of treatment

Comparing the pre- and post-treatment number of parent-child turn-taking between groups.

A parent-child interaction video will be taken; the number of turn-taking will be counted. The greater number of the mentioned language and communication features mean a better outcome.

Baseline, at 6 months and at 12 months after the beginning of treatment
Change from Baseline Mean Length of Utterance at 6 months and 12 months
Zeitfenster: Baseline, at 6 months and at 12 months after the beginning of treatment

Comparing the pre- and post-treatment mean length of utterance between groups.

A parent-child interaction video will be taken; speech of children will be transcribed. The length of utterance will be assessed and the mean length of utterance will be calculated. The longer mean length of utterance mean a better outcome.

Baseline, at 6 months and at 12 months after the beginning of treatment
Change from Baseline Number of Nouns and Verbs at 6 months and 12 months
Zeitfenster: Baseline, at 6 months and at 12 months after the beginning of treatment

Comparing the pre- and post-treatment number of nouns and verbs between groups.

A parent-child interaction video will be taken; speech of children will be transcribed. The number of nouns and verbs will be counted. The greater number of nouns and verbs means a better outcome.

Baseline, at 6 months and at 12 months after the beginning of treatment
Change from Baseline Prosody in terms of loudness variation at 6 months and 12 months
Zeitfenster: Baseline, at 6 months and at 12 months after the beginning of treatment

Comparing the pre- and post-treatment loudness variation between groups.

A parent-child interaction video will be taken. Audio with the speech of children will be extracted. Loudness of the audio will be assessed with Praat, an acoustic analysis software. The reduction of the loudness variation means a better outcome.

Baseline, at 6 months and at 12 months after the beginning of treatment
Change from Baseline Prosody in terms of fundamental frequency at 6 months and 12 months
Zeitfenster: Baseline, at 6 months and at 12 months after the beginning of treatment

Comparing the pre- and post-treatment fundamental frequency between groups.

A parent-child interaction video will be taken. Audio with the speech of children will be extracted. The fundamental frequency of the audio will be assessed with Praat, an acoustic analysis software. The reduction of fundamental frequency means a better outcome.

Baseline, at 6 months and at 12 months after the beginning of treatment
Change from Baseline Communication at 6 months and 12 months
Zeitfenster: Baseline, at 6 months and at 12 months after the beginning of treatment

Comparing the pre- and post-treatment communication ability measured by the Communication domain of Vineland Adaptive Behavior Scales, Third Edition (VABS-3) between groups.

The VABS-3 score v-score ranges from 1 to 24; the higher VABS-3 scores mean a better outcome.

Baseline, at 6 months and at 12 months after the beginning of treatment
Change from Baseline Socialization at 6 months and 12 months
Zeitfenster: Baseline, at 6 months and at 12 months after the beginning of treatment

Comparing the pre- and post-treatment socialization ability measured by the Socialization domain of Vineland Adaptive Behavior Scales, Third Edition (VABS-3) between groups.

The VABS-3 score v-score ranges from 1 to 24; the higher VABS-3 scores mean a better outcome.

Baseline, at 6 months and at 12 months after the beginning of treatment

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. Juli 2022

Primärer Abschluss (Tatsächlich)

31. Januar 2026

Studienabschluss (Tatsächlich)

30. Juni 2026

Studienanmeldedaten

Zuerst eingereicht

29. Juni 2022

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

8. Juli 2022

Zuerst gepostet (Tatsächlich)

13. Juli 2022

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

3. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

30. Oktober 2026

Zuletzt verifiziert

1. Oktober 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren